INTEGRITY IN ACTION - HEALTH CARE COMPLIANCE

August 30, 2012

HEALTH CARE COMPLIANCE IS EVERYONE’S RESPONSIBILITY. DePuy Synthes is known the world over for innovative, life enhancing orthopedic products and neurological solutions and for the values and principles that we embrace while developing these products and making them available to serve patient needs. This is a reputation that we have worked hard to earn and one we are dedicated to protecting and to building into our future.

Spotlight

Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.

OTHER WHITEPAPERS
news image

How Healthcare Providers Are Adapting in the Era of Telehealth, and Why Radiology was Uniquely Suited to Go Hybrid

whitePaper | September 26, 2022

As hospitals and private health offices nationwide slowly begin to emerge from the COVID-induced challenges posed over the last two years, there is a new understanding of, and necessity for, adaptable medical technology and practices.

Read More
news image

Empowering people to live a healthier day

whitePaper | July 1, 2022

Too often health is something we try not to think about. We avoid talking about it. We put it off for another day, a better time. Then, something unexpected happens: an illness, an unfortunate incident, or even, as we’ve seen these last two and a half years, a pandemic.

Read More
news image

Using Clinical Trial Sites’Input to Select the Right Capabilities when Decentralizing Clinical Trials

whitePaper | March 22, 2023

The COVID-19 pandemic has renewed emphasis on innovations to support clinical trial operations. Traditional sites including hospitals and private practices were forced during the height of the pandemic to find novel ways to continue patient care.

Read More
news image

Addressing Total Cost of Care Across the Specialty Population

whitePaper | September 28, 2022

Specialty drugs span a wide range of disease states, from the more prevalent, yet complex, such as multiple sclerosis, to rare and orphan diseases, such as hereditary angioedema (HAE).

Read More
news image

C-suite check-in: The healthcare workforce crisis

whitePaper | December 15, 2022

Every segment in health care is experiencing extraordinary changes in the workforce. Burnout, turnover, rising labor costs and skill gaps are diminishing the supply of qualified workers.

Read More
news image

Test Resource

whitePaper | May 18, 2021

Test Resource The criteria of patient satisfaction have changed dramatically. The priority of your healthcare business is to provide patients the right treatment. But nowadays, you cannot excel in your service

Read More

Spotlight

Haemonetics

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.

Events